Anemia in chronic heart failure: Pathogenetic mechanisms

Journal of Cardiac Failure

Volumn 10, Issue 1 SUPPL., 2004, Pages

  Okonko, Darlington O ^a   Anker, Stefan D ^a,b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

erythropoietin; kidney function; Pathophysiology

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; OXYGEN;

ANEMIA; CLINICAL FEATURE; CYTOKINE PRODUCTION; HEART FAILURE; HEMODILUTION; HUMAN; HYPOXIA; INFLAMMATION; IRON DEFICIENCY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MOLECULAR MECHANICS; OXYGEN CONSUMPTION; OXYGEN TENSION; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; FEMALE; MALE; METABOLISM; PHYSIOLOGY; RISK FACTOR;

ANEMIA; CHRONIC DISEASE; ERYTHROPOIETIN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; RISK FACTORS;

EID: 3042752765     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2004.01.004     Document Type: Article

References (39)

1. McMurray J.J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 83:2000;596-602
2. Cleland J.G., Cohen-Solal A., Aguilar J.C., Dietz R., Eastaugh J., Follath F., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 360:2002;1631-1639
3. Wisniacki N., Aimson P., Lye M. Is anemia a cause or a consequence of heart failure in the elderly? Heart. 85:(Suppl 1):2001;P4
4. Tanner H., Moschovitis G., Kuster G.M., Hullin R., Pfiiffner D., Hess O.M., et al. The prevalence of anemia in chronic heart failure. Int J Cardiol. 86:2002;115-121
5. Cromie N., Lee C., Struthers A.D. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? Heart. 87:2002;377-378
6. Ezekowitz J.A., McAlister F.A., Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 107:2003;223-225
7. Kalra P.R., Bolger A.P., Francis D.P., Genth-Zotz S., Sharma R., Ponikowski P.P., et al. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol. 91:2003;888-891
8. Silverberg D.S., Wexler D., Blum M., Keren G., Sheps D., Leibovitch E., et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 35:2000;1737-1744
9. Silverberg D.S., Wexler D., Sheps D., Blum M., Keren G., Baruch R., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 37:2001;1775-1780
10. Mancini D.M., Katz S.D., Lang C.C., LaManca J., Hudaihed A., Androne A.S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 107:2003;294-299
11. Bauer C., Kurtz A. Oxygen sensing in the kidney and its relation to erythropoietin production. Annu Rev Physiol. 51:1989;845-856
12. Donnelly S. Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Am J Kidney Dis. 38:2001;415-425
13. Volpe M., Tritto C., Testa U., Rao M.A., Martucci R., Mirante A., et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 74:1994;468-473
14. Pham I., Andrivet P., Sediame S., Defouilloy C., Moutereau S., Wirquin V., et al. Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics. Eur J Clin Invest. 31:2001;103-109
15. Jensen J.D., Eiskjaer H., Bagger J.P., Pedersen E.B. Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin. J Intern Med. 233:1993;125-130
16. Fyhrquist F., Karppinen K., Honkanen T., Saijonmaa O., Rosenlof K. High serum erythropoietin levels are normalized during treatment of congestive heart failure with enalapril. J Intern Med. 226:1989;257-260
17. Al-Ahmad A., Rand W.M., Manjunath G., Konstam M.A., Salem D.N., Levey A.S., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 38:2001;955-962
18. Chatterjee B., Nydegger U.E., Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT(1) antagonists. Eur J Heart Fail. 2:2000;393-398
19. Silverberg D.S., Wexler D., Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail. 4:2002;681-686
20. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 16:2002;87-96
21. Anker S.D., Volterrani M., Pflaum C.D., Strasburger C.J., Osterziel K.J., Doehner W., et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol. 38:2001;443-452
22. Anker S.D., Chua T.P., Ponikowski P., Harrington D., Swan J.W., Kox W.J., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 96:1997;526-534
23. Doehner W., Rauchhaus M., Godsland I.F., Egerer K., Niebauer J., Sharma R., et al. Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. Int J Cardiol. 83:2002;73-81
24. Anker S.D., Egerer K.R., Volk H.D. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430
25. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067
26. Gullestad L., Aukrust P. The cytokine network in heart failure: pathogenic importance and potential therapeutic targets. Heart Fail Monit. 2:2001;8-13
27. Torre-Amione G., Bozkurt B., Deswal A., Mann D.L. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol. 14:1999;206-210
28. Sharma R., Anker S.D. Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol. 85:2002;161-171
29. Witte K.K., Clark A.L. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol. 85:2002;23-31
30. Anker S.D., Negassa A., Coats A.J., Afzal R., Poole-Wilson P.A., Cohn J.N., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 361:2003;1077-1083
31. Silagy C.A., McNeil J.J., Donnan G.A., Tonkin A.M., Worsam B., Campion K. Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther. 54:1993;84-89
32. Parsi A., Kleber F.X. Anaemia in heart failure: its diagnosis and management. Eur J Heart Fail. 5:2003;3-4
33. Capes S.E., Gerstein H.C., Negassa A., Yusuf S. Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction. Diabetes Care. 23:2000;377-380
34. Iversen P.O., Woldbaek P.R., Tonnessen T., Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol. 282:2002;R166-R172
35. Bolger A.P., Doehner W., Sharma R., Coats A.J., Anker S. Anaemia in chronic heart failure: the relationship to inflammatory cytokine expression and prognostic importance. Circulation. 106:(Suppl 2):2002;II-570-II-571. 19
36. Abromeit S., Knies C., Schmidt H.B., Werdan K., Rauchhaus M. Systemic inflammation and anaemia in chronic heart failure: a pathophysiological link? Eur Heart J. 24:(Suppl):2003;487
37. Kalra P.R., Anagnostopoulos C., Bolger A.P., Coats A.J., Anker S.D. The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol. 39:2002;1901-1908
38. Anand I.S., Chandrashekhar Y., Ferrari R., Poole-Wilson P.A., Harris P.C. Pathogenesis of oedema in chronic anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J. 70:1993;357-362
39. Androne A.S., Katz S.D., Lund L., LaManca J., Hudaihed A., Hryniewicz K., et al. Hemodilution is common in patients with advanced heart failure. Circulation. 107:2003;226-229